System Maintenance Notice

Please be aware of system downtime for DOHMQA beginning Friday July 24th 6:30PM(EST) until Monday July 27th 6:00AM(EST). Click here for more information. Continue reading

Nonopioid Alternatives Pamphlet

2020 legislation amended the requirements for non-opioid alternatives. Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading

New Legislation Impacting Your Profession

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading

New Coronavirus: COVID-19

The Florida Department of Health (Department) is working closely with the Centers for Disease Control and Prevention (CDC) to closely monitor the current outbreak of 2019 novel coronavirus. Continue reading

Important Notice Regarding Oxervate

The Board of Optometry has approved Oxervate (Cenegermin-bkbj) 0.002% for addition to Rule 64B13-18.002. Continue reading

Electronic Prescribing Requirements

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading

First Quarterly Performance Report Released for the 2019-2020 Fiscal Year

The Quarterly Performance Report for the first quarter of the 2019-2020 fiscal year is now available online. Continue reading

Hepatitis A Public Health Emergency

Florida, like other parts of the United States, is experiencing a Public Health Emergency as a result of Hepatitis A Virus (HAV). Click here for more information. Continue reading

Annual Report & Long-Range Plan Released for the 2018-2019 Fiscal Year

The Annual Report & Long-Range Plan for the 2018-2019 Fiscal Year is now available to view online. Continue reading

Important Notice regarding Dextenza and Klarity-C

The Board of Optometry has approved Dextenza (dexamethasone ophthalmic insert) 0.4 mg and Klarity-C (cyclosporine) 0.1% for addition to Rule 64B13-18.002. Continue reading